ANTX - Financial Reports List - AN2 Therapeutics, Inc. - IntrinsicAlpha

AN2 Therapeutics, Inc. ANTX

Healthcare - Biotechnology - NASDAQ - US

$ 1.19

-1.68 %

$ 35.9 M

Market Cap

-0.77

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	35.92%	36.94%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	55.49%	54.30%
Annual Report	FY	10-K	2024-12-31	0.00%	20.72%	21.66%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	23.70%	22.92%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	8.66%	4.34%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-13.76%	-14.07%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-32.15%	-50.81%
Annual Report	FY	10-K	2023-12-31	0.00%	-56.09%	-64.77%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-53.16%	-54.46%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-63.28%	-60.66%

1